Natera (NTRA) Return on Capital Employed (2015 - 2026)
Natera's (NTRA) quarterly Return on Capital Employed came in at 16.64% in Q1 2026, up 42.0% YoY from 11.72% in Q1 2025, and up 10.38% on a QoQ basis from 18.57% in Q4 2025.
Natera (NTRA) Return on Capital Employed (2015 - 2026) Analysis & Trends
Natera (NTRA) has 12 years of Return on Capital Employed data on file, last reported at 16.64% in Q1 2026.
- Quarterly Return on Capital Employed rose 42.0% year-over-year to 16.64% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.64% (up 42.0% YoY) and the FY2025 annual result came in at 19.51%, down 110.0% from the prior year.
- Return on Capital Employed advanced to 16.64% in Q1 2026, from 18.57% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 16.64% in Q1 2026 to a low of 69.92% in Q3 2022.
- A 5-year average of 37.59% and a median of 33.27% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 2424 bps — and 2024, when it jumped 2829 bps.
- Tracing NTRA's Return on Capital Employed over 5 years: stood at 60.7% in 2022, then soared by 35 bps to 39.25% in 2023, then soared by 56 bps to 17.34% in 2024, then declined by 7 bps to 18.57% in 2025, then increased by 10 bps to 16.64% in 2026.
- The last three Return on Capital Employed figures came in at 16.64% (Q1 2026), 18.57% (Q4 2025), and 26.12% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 10.85% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 8.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.64% |
| Dec 31, 2025 | -18.57% |
| Sep 30, 2025 | -26.12% |
| Jun 30, 2025 | -21.59% |
| Mar 31, 2025 | -17.07% |
| Dec 31, 2024 | -17.34% |
| Sep 30, 2024 | -19.33% |
| Jun 30, 2024 | -26.63% |
| Mar 31, 2024 | -33.27% |
| Dec 31, 2023 | -39.25% |
| Sep 30, 2023 | -47.62% |
| Jun 30, 2023 | -50.82% |
| Mar 31, 2023 | -50.88% |
| Dec 31, 2022 | -60.70% |
| Sep 30, 2022 | -69.92% |
| Jun 30, 2022 | -66.74% |
| Mar 31, 2022 | -56.52% |
| Dec 31, 2021 | -44.38% |
| Sep 30, 2021 | -45.69% |
| Jun 30, 2021 | -45.72% |